Delivery Order SPE2DB24D1205-SPE2DB25FCWCU
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Promacta 75 mg tablets in quantities of 30 units. This firm fixed-price contract, valued at $24,059.26, represents a non-competitive set-aside award and is scheduled for completion by August 11, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Promacta 50 mg tablets in quantities of 30 units. This firm fixed price delivery order, valued at $8,026.53, is scheduled for completion by July 9, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Promacta 12.5 mg tablets (30-count units) under a firm fixed price contract valued at $13,251.75, with completion targeted for October 6, 2025. This competitively awarded, non-set-aside delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract action under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $8,836.12 to AmerisourceBergen Drug Corp for the supply of Promacta 25 mg tablets (30-count packaging) with a completion date of September 4, 2025. The competitive, firm fixed-price award was issued on August 13, 2025, with no set-aside designation. AmerisourceBergen will perform the work at its corporate office located in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $8,026.53 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Promacta 50 mg tablets (30-count units), with an ultimate completion date of October 17, 2025. The award was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement across...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Promacta 75 mg tablets in quantities of 30 units. This firm fixed-price contract, valued at $36,088.89, represents a non-set-aside, competitively awarded procurement supporting federal medical supply requirements. The order is scheduled for completion by October 9, 2025, with performance originating from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $4,417.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30 tablets of Promacta 12.5 mg, with an ultimate completion date of September 23, 2025. This non-set-aside contract represents a child delivery order issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime vendor agreement extending through December 2026. The work will be performed at...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $4,418.06 to supply Promacta 25 mg tablets (30-count units) with an ultimate completion date of August 13, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $26,503.50 to AmerisourceBergen Drug Corp for the supply of Promacta 12.5 mg tablets in quantities of 30 units. This firm fixed price contract, awarded on May 22, 2025, with an ultimate completion date of June 13, 2025, represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $8,026.53 to AmerisourceBergen Drug Corp for the supply of Promacta 50 mg tablets in quantities of 30 units. The contract, issued on July 14, 2025, with an ultimate completion date of August 4, 2025, utilizes firm fixed-price pricing with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCWCUDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $24,079.59 firm fixed-price delivery order on April 24, 2025, for the supply of Promacta 50 mg tablets (30-count units). This non-competitive delivery order is set to be completed by May 15, 2025, with performance conducted at the contractor's Conshohocken, Pennsylvania location. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which carries a $1 billion ceiling and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical supplier to the Defense Health Agency and military healthcare systems nationwide. This delivery order for Promacta, an immunosuppressant medication used to treat thrombocytopenia, exemplifies the contractor's role in fulfilling specialized pharmaceutical procurement needs for federal medical supply chains. The company maintains a substantial portfolio of federal contracts covering a broad range of therapeutic medications and medical supplies, consistently securing awards through competitive processes across multiple therapeutic domains to support military and veteran healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.1k | 4/24/25 |